Balancing The Future

The use of 3D cell cultures is revolutionizing the drug testing industry, improving safety, accuracy and shaking up traditional methods. Could this technology take us into a future where we are able to fully personalize medicine, and maybe, even grow replacement organs? 
 
In this episode of Balancing the Future, Dr. Jan Lichtenberg joins Dana and Micah to explore how 3D cell cultures are changing the trajectory of the drug development and testing landscape, the ethical implications of this technology, and how all this fits into the context of personalized medicine.  
 
Dr. Jan Lichtenberg is CEO and co-founder of InSphero, a company that develops a wide range of 3D cell cultures and three-dimensional microtissues for drug development and screening.   
 
LINKS: 
Jan Lichtenberg on LinkedIn 
InSphero Website 
METTLER TOLEDO Laboratory Solutions Website 
METTLER TOLEDO Laboratory Solutions on LinkedIn 
Dana Clémençon on LinkedIn 
Micah Schweizer on LinkedIn 
 
Join hosts Dana Clémençon and Micah Schweizer on Balancing the Future from METTLER TOLEDO, where they delve into the world of sustainable technology and its transformative impact on our lives.  
 
Each episode features stories from leading innovators, breaking down complex tech advancements into engaging narratives that reveal how these innovations shape our present and future.  
 
From the origins of new technologies to their individual and societal implications, this podcast offers a compelling look at the future of sustainability.

What is Balancing The Future?

Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.

We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology. Like how cultivated foods could shake up both our diets and traditional agriculture, the ways AI could help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.

Each episode offers hopeful conversations with scientists, leaders, and communicators who are making a difference in their fields.

Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode.